Literature DB >> 16704217

A new class of Gd-based DO3A-ethylamine-derived targeted contrast agents for MR and optical imaging.

Anurag Mishra1, Josef Pfeuffer, Ritu Mishra, Jörn Engelmann, Anil K Mishra, Kamil Ugurbil, Nikos K Logothetis.   

Abstract

Synthetic bifunctional probes based on [4,7-bis-carboxymethyl-10-(2-aminoethyl)-1,4,7,10-tetraaza-cyclododec-1-yl]-acetic acid (DO3A-ethylamine) preloaded with gadolinium were prepared for applications in targeted magnetic resonance imaging (MRI) and optical imaging. A convenient route of synthesis is reported, which allowed conjugation of this probe with biomolecules for the preparation of model MR contrast agents for targeted imaging. The conjugated probes have the following interesting properties: GdDO3A-ethylamido-biotin (Gd-9) can be used for targeted imaging using an avidin-biotin system. The fluorescent probe GdDO3A-ethylthiourea-fluorescein (Gd-12) is a bimodal compound, which can be used for both MR and optical imaging. The precursors, DO3A-ethylamidopropyl-maleimide and DO3A-ethyl-isothiocyanate contain a highly reactive moiety, which can interact with free SH-terminals and N-terminals of biological molecules, respectively. In vitro MR relaxivity studies were performed at 300 MHz using different concentrations and chemical environments. MR relaxivity for ligand Gd-9 at pH 7.4, r1 was (3.32 +/- 0.03) s(-1) mM(-1) and r2 was (5.02 +/- 0.14) s(-1) mM(-1). For the mixture of Gd-9 with avidin, at pH 7.4, relaxivity increased linearly with the avidin concentration. A relaxivity enhancement of 45% for r1 and more than 400% for r2 with respect to the unbound biotinylated Gd3+ complex was found at a ratio of 4:1. MR relaxivity for ligand Gd-12, r1 was (5.36 +/- 0.05) s(-1) mM(-1) at pH 7.4. Fluorescence microscopy and spectroscopy of Gd-12-labeled 3T3 mouse fibroblasts showed a concentration-dependent intracellular uptake, accompanied by a slight dose-dependent increase in toxicity up to 150 microM. MR studies on labeled cells indicated a contrast enhancement in both T1- and T2-weighted images by the internalized compound, with the effect being more pronounced in T2-weighted images. Our results indicate that DO3A-ethylamine is a multipurpose precursor, from which various targeted contrast agents can be synthesized after a single-step conjugation with organic/bioorganic molecules.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704217     DOI: 10.1021/bc050295b

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  16 in total

1.  In vivo magnetic resonance imaging and optical imaging comparison of viable and nonviable mesenchymal stem cells with a bifunctional label.

Authors:  Elizabeth Jane Sutton; Tobias D Henning; Sophie Boddington; Stavros Demos; Christian Krug; Reinhardt Meier; John Kornak; Shoujun Zhao; Rick Baehner; Sheida Sharifi; Heike Daldrup-Link
Journal:  Mol Imaging       Date:  2010-10       Impact factor: 4.488

2.  Microscopic visualization of metabotropic glutamate receptors on the surface of living cells using bifunctional magnetic resonance imaging probes.

Authors:  Anurag Mishra; Ritu Mishra; Sven Gottschalk; Robert Pal; Neil Sim; Joern Engelmann; Martin Goldberg; David Parker
Journal:  ACS Chem Neurosci       Date:  2013-11-27       Impact factor: 4.418

Review 3.  Multimodality imaging probes: design and challenges.

Authors:  Angelique Louie
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Rational chemical design of the next generation of molecular imaging probes based on physics and biology: mixing modalities, colors and signals.

Authors:  Hisataka Kobayashi; Michelle R Longmire; Mikako Ogawa; Peter L Choyke
Journal:  Chem Soc Rev       Date:  2011-05-23       Impact factor: 54.564

5.  Biocytin-derived MRI contrast agent for longitudinal brain connectivity studies.

Authors:  Anurag Mishra; Almut Schüz; Jörn Engelmann; Michael Beyerlein; Nikos K Logothetis; Santiago Canals
Journal:  ACS Chem Neurosci       Date:  2011-08-03       Impact factor: 4.418

6.  Hybrid magnetic nanostructures (MNS) for magnetic resonance imaging applications.

Authors:  Mrinmoy De; Stanley S Chou; Hrushikesh M Joshi; Vinayak P Dravid
Journal:  Adv Drug Deliv Rev       Date:  2011-08-06       Impact factor: 15.470

7.  Multimodality and nanoparticles in medical imaging.

Authors:  Wen-Yen Huang; Jason J Davis
Journal:  Dalton Trans       Date:  2011-03-14       Impact factor: 4.390

Review 8.  Molecular imaging agents: impact on diagnosis and therapeutics in oncology.

Authors:  Marc E Seaman; Gianmarco Contino; Nabeel Bardeesy; Kimberly A Kelly
Journal:  Expert Rev Mol Med       Date:  2010-07-15       Impact factor: 5.600

9.  Synthesis and evaluation of a targeted nanoglobular dual-modal imaging agent for MR imaging and image-guided surgery of prostate cancer.

Authors:  Mingqian Tan; Zhen Ye; Daniel Lindner; Susann M Brady-Kalnay; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2013-03-08       Impact factor: 4.200

10.  Transferrin-Decorated Niosomes with Integrated InP/ZnS Quantum Dots and Magnetic Iron Oxide Nanoparticles: Dual Targeting and Imaging of Glioma.

Authors:  Didem Ag Seleci; Viktor Maurer; Firat Baris Barlas; Julian Cedric Porsiel; Bilal Temel; Elcin Ceylan; Suna Timur; Frank Stahl; Thomas Scheper; Georg Garnweitner
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.